Nanchang Dashenlin Chain Pharmacy Co., Ltd.

Dashenlin Pharmaceutical Group Co., Ltd., founded in 1999, is a group enterprise integrating pharmaceutical manufacturing, retail, and wholesale. The company takes the development of pharmacy chains as its foundation. After years of cultivation, its stores are spread across ten domestic provinces including Guangdong, Guangxi, Henan, and Hebei. On July 31, 2017, Dashenlin was officially listed on the main board of the Shanghai Stock Exchange (stock code: 603233.SH). On the first day of listing, it became the industry's market value leader. As of January 2021, its market value exceeded 65 billion. In 2020, Dashenlin Group achieved tax-inclusive operating revenue of 16.13 billion yuan, with over 6,000 stores. Currently, the group has approximately 32,300 employees, including more than 21,000 professional pharmaceutical technicians. Dashenlin takes "serving human health with full enthusiasm" as its corporate mission, adheres to the business philosophy of "providing absolutely qualified products at the lowest possible price and satisfying customer needs to the greatest extent" and the service philosophy of "we are actors, customers are judges," and has forged a distinct corporate character—taking it as its duty to promote industry development and actively undertaking social responsibility.